• VOLOCIXIMAB CHEMBL2108061 Antineoplastic

    Alternate Names:

    Volociximab
    M200

    Drug Info:

    FDA Approval not approved
    Drug Class monoclonal antibody
    Drug Indications antineoplastic agent
    (0 More Sources)

    Publications:

  • Interaction Types:
    antagonist
    antibody

    Interaction Info:
    Notes Targets ALPHA-5/BETA-1 INTEGRIN
    Mechanism of Interaction Integrin alpha-5/beta-1 antagonist
    Direct Interaction yes

    Publications:

  • Interaction Types:
    antagonist
    antibody

    Interaction Info:
    Notes Targets ALPHA-5/BETA-1 INTEGRIN
    Trial Name volociximab, E10030, Eos200-4
    Novel drug target Established target

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:
    Trial Name volociximab, E10030, Eos200-4
    Novel drug target Established target

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    FDA Approval not approved
    Drug Indications antineoplastic agent
    Drug Class monoclonal antibody

    Publications:

    • Version: 12-May-2016

    Alternate Names:
    VOLOCIXIMAB Primary Drug Name
    VOLOCIXIMAB Drug Generic Name
    M200 Drug Synonym

    Drug Info:

    Publications:

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: